Objectives: To evaluate the spectrum of neuromyelitis optica (NMO), includi
ng characteristics of the index events (optic neuritis [ON]) and myelitis),
neuroimaging, CSF, and serologic studies, and to evaluate the long-term co
urse. Methods: Review of 71 patients with NMO evaluated at the Mayo Clinic
between 1950 and 1997. Results. NMO was either monophasic or relapsing. Pat
ients with a monophasic course (n = 23) usually presented with rapidly sequ
ential index events (median 5 days) with moderate recovery. Most with a rel
apsing course (n = 48) had an extended interval between index events (media
n 166 days) followed within 3 years by clusters of severe relapses isolated
to the optic nerves and spinal cord. Most relapsing patients developed sev
ere disability in a stepwise manner, and one-third died because of respirat
ory failure. Features of NMO distinct from "typical" MS included >50 cells/
mm(3) in CSF (often polymorphonuclear), normal initial brain MRI, and lesio
ns extending over three or more vertebral segments on spinal cord MRI. Conc
lusions: Clinical, laboratory, and imaging features generally distinguish n
euromyelitis optica from MS. Patients with relapsing optic neuritis and mye
litis may have neuromyelitis optica rather than MS. Patients with a relapsi
ng course of neuromyelitis optica have a poor prognosis and frequently deve
lop respiratory failure during attacks of cervical myelitis.